Form 4 for BHVN Biohaven Ltd.

Accepted 2026-01-07 00:00:00 ET · period of report 2026-01-05 · accession 0001898799-26-000002 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2026-01-07	2026-01-05	BHVN	Buten Matthew	CFO	F - Tax	$9.93	-2,594	195.7K	-1%	-$25.8K
D	2026-01-07	2026-01-05	BHVN	Buten Matthew	CFO	M - OptEx	$0.00	+4,250	198.2K	+2%	$0
D	2026-01-07	2026-01-05	BHVN	Buten Matthew	CFO	M - OptEx	$0.00	-4,250	8,500	-33%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Shares	2026-01-05	F	D	2,594	$9.93	195,652	D	—	—	(F2) No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units. (F1) This balance includes 544 shares that were acquired through the Biohaven Employee Share Purchase Plan on May 31, 2025.
2	Common	Common Shares	2026-01-05	M	A	4,250	$0.00	198,246	D	—	—	(F1) This balance includes 544 shares that were acquired through the Biohaven Employee Share Purchase Plan on May 31, 2025.
3	Derivative	Restricted Share Unit Award	2026-01-05	M	D	4,250	$0.00	8,500	D	— · — to —	4,250 Common Shares	(F3) Each restricted share unit represents the contingent right to receive one common share of the Issuer. (F4) The reporting person was granted 17,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date. (F5) Not applicable.